U.S. Jury Rejects GlaxoSmithKline Antitrust Claims vs Abbott Laboratories

March 31, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

(Reuters) - A U.S. jury rejected GlaxoSmithKline's antitrust claims against Abbott Laboratories over allegations of unfair HIV drug pricing, after Britain's biggest drugmaker had asked for hundreds of millions in damages.

Twitter
LinkedIn
Facebook
Email
Print

Legal

GlaxoSmithKline Abbott Laboratories